通过纳米颗粒配方大幅提高胡椒碱的水溶性是增强其脑摄取的最关键因素。

IF 6.6 2区 医学 Q1 NANOSCIENCE & NANOTECHNOLOGY
International Journal of Nanomedicine Pub Date : 2025-03-30 eCollection Date: 2025-01-01 DOI:10.2147/IJN.S506827
Jiahao Li, Sharon Shui Yee Leung, Edwin Ho Yin Chan, Cuiping Jiang, Evelyn Tze Yin Ho, Zhong Zuo
{"title":"通过纳米颗粒配方大幅提高胡椒碱的水溶性是增强其脑摄取的最关键因素。","authors":"Jiahao Li, Sharon Shui Yee Leung, Edwin Ho Yin Chan, Cuiping Jiang, Evelyn Tze Yin Ho, Zhong Zuo","doi":"10.2147/IJN.S506827","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Piperine, the major component in <i>Piper retrofractum</i> and <i>Piper nigrum</i>, had potential therapeutic effects on central nervous system diseases such as Alzheimer's disease, Parkinson's disease, epilepsy and fragile X-associated tremor/ataxia syndrome. However, its low aqueous solubility (0.04 mg/mL) limits brain uptake and pharmacological investigations at higher doses. In the current study, formulation strategies and routes of administration were assessed to enhance systemic and brain uptake of piperine.</p><p><strong>Methods: </strong>Formulation of piperine nanoparticles (PIP NPs) was developed to enhance its solubility. PIP NPs were prepared using flash nanoprecipitation via a four-stream Multi-Inlet Vortex Mixer, employing an aqueous solution of poloxamer 188 and an ethanolic solution containing piperine and Eudragit L100-55. The process was optimized using the Design of Experiments to minimize the particle size and maximize the encapsulation efficiency of piperine. Additionally, we investigated the impact of administrating PIP NPs via oral and intranasal routes on its systemic and brain uptake.</p><p><strong>Results: </strong>The optimized PIP NPs formulation exhibited a particle size of 171.45±2.38 nm, polydispersity index of 0.27±0.01, zeta potential of -43.71±5.11 mV, encapsulation efficiency of 92.49±1.92% and drug loading of 15.07±0.09%. Fourier-transform infrared spectroscopy confirmed the successful encapsulation of piperine into nanoparticles. The PIP NPs could significantly increase the aqueous solubility of piperine from 0.04 mg/mL to 52.31±0.9 mg/mL and release piperine with a 12.83-fold higher rate than that from piperine suspension. Both oral and intranasal administrations of PIP NPs to C57BL/6 mice at 20 mg/kg demonstrated an increase in AUC<sub>0-120min</sub> for both plasma (7.9-10 times) and brain (4.7-5.0 times) comparing to that from piperine suspension, with no significant difference between these two routes.</p><p><strong>Discussion: </strong>Our findings suggested that increasing solubility rather than changing the administration route served as the most critical step to enhance the brain uptake of piperine.</p>","PeriodicalId":14084,"journal":{"name":"International Journal of Nanomedicine","volume":"20 ","pages":"3945-3959"},"PeriodicalIF":6.6000,"publicationDate":"2025-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967364/pdf/","citationCount":"0","resultStr":"{\"title\":\"Significantly Increased Aqueous Solubility of Piperine via Nanoparticle Formulation Serves as the Most Critical Factor for Its Brain Uptake Enhancement.\",\"authors\":\"Jiahao Li, Sharon Shui Yee Leung, Edwin Ho Yin Chan, Cuiping Jiang, Evelyn Tze Yin Ho, Zhong Zuo\",\"doi\":\"10.2147/IJN.S506827\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Piperine, the major component in <i>Piper retrofractum</i> and <i>Piper nigrum</i>, had potential therapeutic effects on central nervous system diseases such as Alzheimer's disease, Parkinson's disease, epilepsy and fragile X-associated tremor/ataxia syndrome. However, its low aqueous solubility (0.04 mg/mL) limits brain uptake and pharmacological investigations at higher doses. In the current study, formulation strategies and routes of administration were assessed to enhance systemic and brain uptake of piperine.</p><p><strong>Methods: </strong>Formulation of piperine nanoparticles (PIP NPs) was developed to enhance its solubility. PIP NPs were prepared using flash nanoprecipitation via a four-stream Multi-Inlet Vortex Mixer, employing an aqueous solution of poloxamer 188 and an ethanolic solution containing piperine and Eudragit L100-55. The process was optimized using the Design of Experiments to minimize the particle size and maximize the encapsulation efficiency of piperine. Additionally, we investigated the impact of administrating PIP NPs via oral and intranasal routes on its systemic and brain uptake.</p><p><strong>Results: </strong>The optimized PIP NPs formulation exhibited a particle size of 171.45±2.38 nm, polydispersity index of 0.27±0.01, zeta potential of -43.71±5.11 mV, encapsulation efficiency of 92.49±1.92% and drug loading of 15.07±0.09%. Fourier-transform infrared spectroscopy confirmed the successful encapsulation of piperine into nanoparticles. The PIP NPs could significantly increase the aqueous solubility of piperine from 0.04 mg/mL to 52.31±0.9 mg/mL and release piperine with a 12.83-fold higher rate than that from piperine suspension. Both oral and intranasal administrations of PIP NPs to C57BL/6 mice at 20 mg/kg demonstrated an increase in AUC<sub>0-120min</sub> for both plasma (7.9-10 times) and brain (4.7-5.0 times) comparing to that from piperine suspension, with no significant difference between these two routes.</p><p><strong>Discussion: </strong>Our findings suggested that increasing solubility rather than changing the administration route served as the most critical step to enhance the brain uptake of piperine.</p>\",\"PeriodicalId\":14084,\"journal\":{\"name\":\"International Journal of Nanomedicine\",\"volume\":\"20 \",\"pages\":\"3945-3959\"},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2025-03-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967364/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Nanomedicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/IJN.S506827\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"NANOSCIENCE & NANOTECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nanomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJN.S506827","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"NANOSCIENCE & NANOTECHNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

简介:胡椒碱是胡椒(Piper retrofractum)和黑胡椒(Piper nigrum)中的主要成分,对阿尔茨海默病、帕金森病、癫痫和脆性 X 相关震颤/共济失调综合征等中枢神经系统疾病具有潜在的治疗作用。然而,其较低的水溶性(0.04 毫克/毫升)限制了大剂量时的脑吸收和药理学研究。本研究评估了提高哌啶全身和脑吸收的配方策略和给药途径:方法:开发了胡椒碱纳米颗粒(PIP NPs)的配方,以提高其溶解度。PIP NPs的制备采用闪速纳米沉淀法,通过四流多入口漩涡混合器,使用poloxamer 188水溶液和含有哌啶和Eudragit L100-55的乙醇溶液。我们采用实验设计法对工艺进行了优化,以尽量减小粒径,最大限度地提高胡椒碱的封装效率。此外,我们还研究了通过口服和鼻内途径给药 PIP NPs 对其全身和脑吸收的影响:结果:优化后的 PIP NPs 配方粒径为 171.45±2.38 nm,多分散指数为 0.27±0.01,zeta 电位为 -43.71±5.11 mV,包封效率为 92.49±1.92%,载药量为 15.07±0.09%。傅立叶变换红外光谱证实哌啶成功地被封装到纳米颗粒中。PIP NPs能将哌啶的水溶性从0.04 mg/mL显著提高到52.31±0.9 mg/mL,哌啶的释放率是哌啶混悬液的12.83倍。给 C57BL/6 小鼠口服和鼻内注射 20 mg/kg 的 PIP NPs 后,血浆(7.9-10 倍)和大脑(4.7-5.0 倍)的 AUC0-120min 均比哌啶混悬液高,两种途径之间无显著差异:讨论:我们的研究结果表明,提高哌啶的溶解度而不是改变给药途径是提高哌啶脑吸收的最关键步骤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Significantly Increased Aqueous Solubility of Piperine via Nanoparticle Formulation Serves as the Most Critical Factor for Its Brain Uptake Enhancement.

Introduction: Piperine, the major component in Piper retrofractum and Piper nigrum, had potential therapeutic effects on central nervous system diseases such as Alzheimer's disease, Parkinson's disease, epilepsy and fragile X-associated tremor/ataxia syndrome. However, its low aqueous solubility (0.04 mg/mL) limits brain uptake and pharmacological investigations at higher doses. In the current study, formulation strategies and routes of administration were assessed to enhance systemic and brain uptake of piperine.

Methods: Formulation of piperine nanoparticles (PIP NPs) was developed to enhance its solubility. PIP NPs were prepared using flash nanoprecipitation via a four-stream Multi-Inlet Vortex Mixer, employing an aqueous solution of poloxamer 188 and an ethanolic solution containing piperine and Eudragit L100-55. The process was optimized using the Design of Experiments to minimize the particle size and maximize the encapsulation efficiency of piperine. Additionally, we investigated the impact of administrating PIP NPs via oral and intranasal routes on its systemic and brain uptake.

Results: The optimized PIP NPs formulation exhibited a particle size of 171.45±2.38 nm, polydispersity index of 0.27±0.01, zeta potential of -43.71±5.11 mV, encapsulation efficiency of 92.49±1.92% and drug loading of 15.07±0.09%. Fourier-transform infrared spectroscopy confirmed the successful encapsulation of piperine into nanoparticles. The PIP NPs could significantly increase the aqueous solubility of piperine from 0.04 mg/mL to 52.31±0.9 mg/mL and release piperine with a 12.83-fold higher rate than that from piperine suspension. Both oral and intranasal administrations of PIP NPs to C57BL/6 mice at 20 mg/kg demonstrated an increase in AUC0-120min for both plasma (7.9-10 times) and brain (4.7-5.0 times) comparing to that from piperine suspension, with no significant difference between these two routes.

Discussion: Our findings suggested that increasing solubility rather than changing the administration route served as the most critical step to enhance the brain uptake of piperine.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International Journal of Nanomedicine
International Journal of Nanomedicine NANOSCIENCE & NANOTECHNOLOGY-PHARMACOLOGY & PHARMACY
CiteScore
14.40
自引率
3.80%
发文量
511
审稿时长
1.4 months
期刊介绍: The International Journal of Nanomedicine is a globally recognized journal that focuses on the applications of nanotechnology in the biomedical field. It is a peer-reviewed and open-access publication that covers diverse aspects of this rapidly evolving research area. With its strong emphasis on the clinical potential of nanoparticles in disease diagnostics, prevention, and treatment, the journal aims to showcase cutting-edge research and development in the field. Starting from now, the International Journal of Nanomedicine will not accept meta-analyses for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信